Resultados globales: 2 registros encontrados en 0.02 segundos.
Artículos, Encontrados 2 registros
Artículos Encontrados 2 registros  
1.
33 p, 2.0 MB Diagnosis and management of AML in adults : 2022 recommendations from an international expert panel on behalf of the ELN / Döhner, Hartmut (Ulm University Hospital. Department of Internal Medicine III) ; Wei, Andrew H. (Peter MacCallum Cancer Centre. Royal Melbourne Hospital and University of Melbourne. Department of Haematology) ; Appelbaum, Frederick (University of Washington. Fred Hutchinson Cancer Research Center) ; Craddock, Charles (Centre for Clinical Haematology. Queen Elizabeth Hospital. University of Birminham) ; DiNardo, Courtney D. (The University of Texas MD Anderson Cancer Center. Department of Leukemia) ; Dombret, Hervé (Saint-Louis Institute for Research. Université de Paris. Hôpital Saint-Louis. Assistance Publique-Hôpitaux de Paris. Department of Hematology) ; Ebert, Benjamin L. (Dana-Farber Cancer Institute (Boston, Estats Units d'Amèrica)) ; Fenaux, Pierre (Service d'Hématologie Séniors. Hôpital Saint-Louis. Assistance Publique-Hôpitaux de Paris) ; Godley, Lucy A. (The University of Chicago. Section of Hematology/Oncology. Department of Medicine) ; Hasserjian, Robert P (Massachusetts General Hospital) ; Larson, Richard A (University of Chicago. Department of Medicine and Comprehensive Cancer Center) ; Levine, Ross L. (Memorial Sloan Kettering Cancer Center. Human Oncology and Pathogenesis Program and Leukemia Service. Department of Medicine) ; Miyazaki, Yasushi (Atomic Bomb Disease Institute. Nagasaki University. Department of Hematology) ; Niederwieser, Dietger (University of Leipzig) ; Ossenkoppele, Gert (Department of Haematology. Amsterdam UMC. Location VU University Medical Center) ; Röllig, Christoph (Department of Internal Medicine I. University Hospital Carl Gustav Carus TU Dresden) ; Sierra, Jorge (Institut d'Investigació Biomèdica Sant Pau) ; Stein, Eytan M. (Leukemia Service. Department of Medicine. Memorial Sloan Kettering Cancer Center) ; Tallman, Martin S. (Leukemia Service. Department of Medicine. Memorial Sloan Kettering Cancer Center) ; Tien, Hwei-Fang F. (Division of Hematology. Department of Internal Medicine. National Taiwan University Hospital) ; Wang, Jianxiang (Institute of Hematology and Blood Diseases Hospital. Chinese Academy of Medical Sciences & Peking Union Medical College) ; Wierzbowska, Agnieszka (Department of Hematology. Medical University of Lodz) ; Löwenberg, Bob (Department of Hematology. Erasmus University Medical Center Rotterdam and Erasmus MC Cancer Institute)
The 2010 and 2017 editions of the European LeukemiaNet (ELN) recommendations for diagnosis and management of acute myeloid leukemia (AML) in adults are widely recognized among physicians and investigators. [...]
2022 - 10.1182/blood.2022016867
Blood, Vol. 140 Núm. 12 (september 2022) , p. 1345-1377  
2.
5 p, 324.7 KB The European Cancer Patient's Bill of Rights, update and implementation 2016 / Højgaard, Liselotte (Kobenhavns Universitet) ; Löwenberg, Bob (Erasmus University Medical Center) ; Selby, Peter (University of Leeds) ; Lawler, Mark (European Cancer Concord) ; Banks, Ian (University of Leeds) ; Law, Kate (European Cancer Concord) ; Albreht, Tit (Institut za varovanje zdravja Republike Slovenija) ; Armand, Jean-Pierre (Gustave Roussy) ; Barbacid, Mariano (Centro Nacional de Investigaciones Oncológicas) ; Barzach, Michèle (IHU Strasbourg Board of Trustees) ; Bergh, Jonas (Karolinska Institutet (Estocolm, Suècia)) ; Cameron, David (University of Edinburgh) ; Conte, Pierfranco (Istituto Oncologico Veneto) ; de Braud, Filippo (National Cancer Institute) ; de Gramont, Aimery (Institut Hospitalier Franco-Britannique) ; De Lorenzo, Francesco (European Cancer Patient Coalition) ; Diehl, Volker (Universität zu Köln) ; Diler, Sarper (Myeloma Patients Europe) ; Erdem, Sema (Europa Donna) ; Geissler, Jan (European Patients Academy on Therapeutic Innovation) ; Gore-Booth, Jola (EuropaColon) ; Henning, Geoffrey (EuropaColon) ; Horgan, Denis (European Alliance for Personalised Medicine) ; Jassem, Jacek (Medical University of Gdansk) ; Johnson, Peter (Cancer Research UK) ; Kaasa, Stein (Norges Teknisk-Naturvitenskapelige Universitet) ; Kapitein, Peter (Inspire2Live) ; Karjalainen, Sakari (Association of European Cancer Leagues) ; Kelly, Joan (Irish Cancer Society) ; Kienesberger, Anita (Austrian Childhood Cancer Organisation) ; La Vecchia, Carlo (Universita degli Studi di Milano) ; Lacombe, Denis (European Organisation for Research and Treatment of Cancer) ; Lindahl, Tomas (Francis Crick Institute) ; Luzzatto, Lucio (Universita degli Studi di Firenze) ; Malby, Rebecca (London South Bank University) ; Mastris, Ken (Europa Uomo) ; Meunier, Françoise (European Organisation for Research and Treatment of Cancer) ; Murphy, Martin (Society for Translational Oncology) ; Naredi, Peter (European Cancer Organisation) ; Nurse, Paul (Francis Crick Institute) ; Oliver, Kathy (International Brain Tumour Alliance) ; Pearce, Jonathan (Lymphoma Association) ; Pelouchov, Jana (European Cancer Patient Coalition) ; Piccart, Martine (Institut Jules Bordet) ; Pinedo, Bob (VuMC Cancer Center) ; Spurrier-Bernard, Gilly (Melanoma Patient Network Europe) ; Sullivan, Richard (Kings Health Partners Integrated Cancer Centre) ; Tabernero, Josep (Vall d'Hebron Institut d'Oncologia) ; Van de Velde, Cornelis (Leids Universitair Medisch Centrum) ; van Herk, Bert (Spaarne Gasthuis) ; Vedsted, Peter (Aarhus Universitet) ; Waldmann, Anita (Leukaemiehilfe RHEIN-MAIN) ; Weller, David (University of Edinburgh) ; Wilking, Nils (Skåne University Hospital (Suècia)) ; Wilson, Roger (Sarcoma Patients EuroNet EV) ; Yared, Wendy (Association of European Cancer Leagues) ; Zielinski, Christoph C (European Society for Medical Oncology) ; zur Hausen, Harald (University of Heidelberg) ; Le Chevalier, Thierry (Institute Gustave Roussy) ; Johnston, Patrick (European Cancer Concord) ; Universitat Autònoma de Barcelona
In this implementation phase of the European Cancer Patient's Bill of Rights (BoR), we confirm the following three patient-centred principles that underpin this initiative: The key aspects of working towards implementing the BoR are:.
2017 - 10.1136/esmoopen-2016-000127
ESMO open, Vol. 1 (january 2017)  

Vea también: autores con nombres similares
2 Lowenberg, B.
2 Lowënberg, B.
2 Löwenberg, B.
¿Le interesa recibir alertas sobre nuevos resultados de esta búsqueda?
Defina una alerta personal vía correo electrónico o subscríbase al canal RSS.